Exercise Physiology and Post-Exertional Malaise
Full Citation:: Franklin JD, Graham M, the Workwell Foundation. The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis. International Journal of Environmental Research and Public Health. 2020;17(24):9575. DOI:: 10.3390/ijerph17249575 PMCID:: PMC7765094 Key Findings:: Day 2 CPET shows decreased VO2max and workload unique to ME/CFS.
Full Citation:: Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Pediatrics. 2018;6:242. DOI:: 10.3389/fped.2018.00242
Full Citation:: Lim E-J, Kang E-B, Jang E-S, Son C-G. The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis. Journal of Clinical Medicine. 2020;9(12):4040. DOI:: 10.3390/jcm9124040 PMID:: 33327624 PMCID:: PMC7765094 Published:: December 14, 2020 Study Design:: Meta-analysis of two-day CPET studies in ME/CFS Key Findings:: Meta-analysis of 5 studies (n=98 ME/CFS, n=51 controls) demonstrating that the second-day CPET shows significantly reduced oxygen consumption, workload, and peak heart rate compared to day 1, which is pathognomonic for ME/CFS. Post-exertional reduction in VO2max provides objective biomarker for post-exertional malaise. Day 2 impairment correlates with symptom severity. Relevance:: Landmark meta-analysis establishing two-day CPET as best-validated objective test for PEM in ME/CFS. Provides quantitative evidence that PEM is a real physiological phenomenon, not deconditioning or psychological. Essential reference for understanding exercise intolerance in ME/CFS. Certainty:: High (systematic meta-analysis, reproducible findings, consistent across included studies, published open-access in Journal of Clinical Medicine).
Full Citation:: Keller BA, Receno CN, Franconi CJ, et al. Cardiopulmonary and Metabolic Responses During a 2-Day CPET in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Translating Reduced Oxygen Consumption to Impairment Status to Treatment Considerations. Journal of Translational Medicine. 2024;22(1):627. DOI:: 10.1186/s12967-024-05410-5 PMID:: 38965566 PMCID:: PMC11229500 Published:: July 5, 2024 Study Design:: Cross-sectional mechanistic study with 2-day CPET Sample Size:: ME/CFS patients (n unspecified in abstract; full sample available in published manuscript) Key Findings:: Two-day CPET demonstrates: (1) reduced peak VO2 on day 2 vs day 1; (2) chronotropic incompetence with inadequate heart rate response to exercise; (3) metabolic abnormalities including reduced oxygen utilization efficiency; (4) anaerobic threshold changes suggesting mitochondrial dysfunction; (5) correlation between CPET impairment and objective disability metrics. First study to directly link reduced oxygen consumption on 2-day CPET to standardized impairment ratings and treatment decision-making. Relevance:: Provides translational framework connecting two-day CPET findings to clinical disability assessment and guide therapeutic interventions. Demonstrates that reduced VO2 is not deconditioning but reflects true metabolic/mitochondrial dysfunction. Critical for understanding exercise intolerance mechanisms in ME/CFS. Certainty:: High (recent peer-reviewed study in Journal of Translational Medicine, mechanistic detail, published with supplementary data; builds on established CPET methodology).
Full Citation:: Two-day cardiopulmonary exercise testing in long COVID post-exertional malaise diagnosis. Respiratory Medicine and Research. 2024;85:101551. DOI:: 10.1016/j.resmer.2024.101551
Full Citation:: Recovery time from two-day CPET in ME/CFS. Cornell Center for Enervating NeuroImmune Disease. 2024. URL:: https://neuroimmune.cornell.edu/news/recovery-from-two-day-cpet-in-me-cfs/ Key Findings:: Recovery \(\sim\) 13 days in ME/CFS vs \(\sim\) 2 days in sedentary controls.
1 Davenport et al. 2025 — Effort and Deconditioning Are Not Valid Explanations of ME/CFS
Full Citation:: Davenport TE, Scheibenbogen C, Zinn MA, et al. Altered effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndrome. Nature Communications. 2025;16:9176. (Davenport et al. 2025) DOI:: 10.1038/s41467-025-64538-0 Study Design:: Matters Arising (formal rebuttal) of Walitt et al. 2024 deep-phenotyping study Key Findings::
- Single CPET cannot characterize PEM, which requires measuring the response to an initial exertional provocation; 2-day CPET is the correct paradigm and the IOM cautioned a single test may be insufficient
- Deconditioning and PEM are not mutually exclusive, so deconditioned-like features cannot explain PEM
- Exercise HR was lower (not elevated) in post-infectious ME/CFS vs healthy volunteers — inconsistent with deconditioning, consistent with chronotropic incompetence and impaired oxidative metabolism
- PEM is not mere discomfort but profound multi-symptom exacerbation (IOM systemic exertion intolerance disease)
- Study underpowered (8 PI-ME/CFS + 9 healthy volunteers completed CPET), lacked deconditioned control matching, and omitted outcome-order documentation from the abstractConclusion:: The effort-preference and deconditioning framing is not supported by the physiological data; the findings better fit intrinsic metabolic and autonomic limitation. Limitations:: Correspondence (no new data); underlying CPET cohort small; relies on secondary interpretation of Walitt’s data. Certainty:: 0.70 (discounted; ME/CFS population weight 1.00)
2 Davenport et al. 2019 — Chronotropic Intolerance in ME/CFS
Full Citation:: Davenport TE, Lehnen M, Stevens SR, VanNess JM, Stevens J, Snell CR. Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Frontiers in Pediatrics. 2019;7:82. (Davenport et al. 2019) DOI:: 10.3389/fped.2019.00082 Key Findings:: Chronotropic incompetence is an overlooked contributor to symptoms and activity limitation in ME/CFS, limiting energy production and utilization during exertion. Conclusion:: Supports the interpretation that lower exercise HR in ME/CFS reflects intrinsic chronotropic limitation rather than deconditioning. Certainty:: 0.65 (discounted; ME/CFS weight 1.00)
3 van Campen et al. 2023 — Orthostatic Chronotropic Incompetence in ME/CFS
Full Citation:: van Campen CMC, Verheugt FWA, Rowe PC, Visser FC. Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). IBRO Neuroscience Reports. 2023;15:1-10. Campen et al. (2023) DOI:: 10.1016/j.ibneur.2023.04.005 Key Findings:: Chronotropic incompetence is present in a subset of ME/CFS patients under orthostatic challenge, consistent with impaired heart-rate response to demand. Certainty:: 0.70 (discounted; ME/CFS weight 1.00)
4 Miwa 2023 — Orthostatic Intolerance and Chronotropic Incompetence in ME/CFS
Full Citation:: Miwa K. Orthostatic Intolerance and Chronotropic Incompetence in Patients With Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Circulation Reports. 2023;5(2):55-61. (Miwa 2023) DOI:: 10.1253/circrep.cr-22-0114 Key Findings:: Independent replication of orthostatic intolerance with chronotropic incompetence in ME/CFS, supporting a cardiovascular component of exertional limitation. Certainty:: 0.60 (discounted; ME/CFS weight 1.00)
5 Cook et al. 2022 — Cardiopulmonary and Perceptual Responses in ME/CFS (MCAM)
Full Citation:: Cook DB, VanRiper S, Dougherty RJ, Lindheimer JB, Falvo MJ, Chen Y, Lin JM-S, Unger ER. Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study. PLOS ONE. 2022;17(3):e0265315. (Cook et al. 2022) DOI:: 10.1371/journal.pone.0265315 Key Findings:: Fitness-matched comparison showing chronotropic and perceptual differences in ME/CFS during exercise that are not explained by deconditioning. Certainty:: 0.70 (discounted; ME/CFS weight 1.00)
6 Treadway et al. 2009 — The EEfRT Effort-for-Rewards Task (Validation)
Full Citation:: Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the ‘EEfRT’? The Effort Expenditure for Rewards Task as an Objective Measure of Motivation and Anhedonia. PLOS ONE. 2009;4(8):e6598. (Treadway et al. 2009) DOI:: 10.1371/journal.pone.0006598 Key Findings:: The EEfRT was validated as a motivation measure in healthy volunteers and psychiatric populations, with an explicit requirement that tasks be easy enough not to induce fatigue — a requirement not met in the Walitt ME/CFS application. Conclusion:: Supports the critique that the EEfRT measured inability rather than altered preference in ME/CFS. Certainty:: 0.34 (raw 0.45, general-population weight 0.75)